Assenagon Asset Management S.A. Has $2.79 Million Position in Henry Schein, Inc. $HSIC

Assenagon Asset Management S.A. lowered its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 43.7% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 37,811 shares of the company’s stock after selling 29,370 shares during the quarter. Assenagon Asset Management S.A.’s holdings in Henry Schein were worth $2,787,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in HSIC. Invesco Ltd. raised its holdings in Henry Schein by 4.1% in the 3rd quarter. Invesco Ltd. now owns 4,731,698 shares of the company’s stock worth $314,043,000 after acquiring an additional 184,763 shares during the period. Dimensional Fund Advisors LP lifted its position in shares of Henry Schein by 8.5% during the 4th quarter. Dimensional Fund Advisors LP now owns 2,816,317 shares of the company’s stock worth $212,865,000 after purchasing an additional 220,149 shares during the last quarter. Ameriprise Financial Inc. lifted its position in shares of Henry Schein by 11.3% during the 3rd quarter. Ameriprise Financial Inc. now owns 2,523,014 shares of the company’s stock worth $167,453,000 after purchasing an additional 256,156 shares during the last quarter. Southpoint Capital Advisors LP boosted its stake in Henry Schein by 38.9% during the 4th quarter. Southpoint Capital Advisors LP now owns 2,500,000 shares of the company’s stock valued at $188,950,000 after purchasing an additional 700,000 shares during the period. Finally, Bank of Montreal Can boosted its stake in Henry Schein by 3,655.7% during the 4th quarter. Bank of Montreal Can now owns 2,144,773 shares of the company’s stock valued at $162,102,000 after purchasing an additional 2,087,666 shares during the period. Institutional investors and hedge funds own 96.62% of the company’s stock.

Analyst Ratings Changes

A number of analysts have issued reports on HSIC shares. UBS Group reaffirmed a “neutral” rating and issued a $85.00 target price (down from $87.00) on shares of Henry Schein in a report on Wednesday, May 6th. Leerink Partners reissued a “market perform” rating on shares of Henry Schein in a research report on Monday, March 9th. Wall Street Zen downgraded shares of Henry Schein from a “strong-buy” rating to a “buy” rating in a research note on Sunday, April 26th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Henry Schein in a research report on Monday, May 4th. Finally, Morgan Stanley reiterated an “underweight” rating and set a $64.00 target price (up from $61.00) on shares of Henry Schein in a research note on Friday, April 24th. Seven equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $87.85.

Insider Buying and Selling

In other news, Director William K. Daniel bought 10,000 shares of Henry Schein stock in a transaction that occurred on Monday, May 11th. The stock was purchased at an average cost of $69.19 per share, with a total value of $691,900.00. Following the completion of the transaction, the director directly owned 20,000 shares in the company, valued at $1,383,800. This trade represents a 100.00% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.89% of the stock is currently owned by company insiders.

Henry Schein Stock Down 0.9%

HSIC stock opened at $83.52 on Wednesday. Henry Schein, Inc. has a twelve month low of $61.94 and a twelve month high of $89.29. The company has a quick ratio of 0.75, a current ratio of 1.36 and a debt-to-equity ratio of 0.59. The company has a market cap of $9.51 billion, a PE ratio of 25.23, a price-to-earnings-growth ratio of 1.62 and a beta of 0.82. The business’s 50-day simple moving average is $76.77 and its 200 day simple moving average is $76.87.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings results on Tuesday, May 5th. The company reported $1.32 EPS for the quarter, beating the consensus estimate of $1.20 by $0.12. Henry Schein had a return on equity of 15.44% and a net margin of 2.95%.The firm had revenue of $3.37 billion during the quarter, compared to analysts’ expectations of $3.34 billion. During the same quarter in the prior year, the firm posted $1.15 EPS. The company’s revenue for the quarter was up 6.3% on a year-over-year basis. Henry Schein has set its FY 2026 guidance at 5.230-5.370 EPS. On average, research analysts anticipate that Henry Schein, Inc. will post 5.32 earnings per share for the current year.

Henry Schein Profile

Henry Schein, Inc is a leading global distributor of healthcare products and services, primarily serving office-based dental, medical and animal health practitioners. The company operates through three principal segments—Schein Dental, Schein Medical and Animal Health—each offering a comprehensive portfolio of consumable products, equipment, instruments and related value-added services. With a focus on improving practice efficiency and patient care, Henry Schein provides everything from dental restorative materials and orthodontic appliances to vaccines, pharmaceuticals and diagnostic devices for physicians, as well as pet health products and veterinary equipment for animal health professionals.

In addition to its broad product offering, Henry Schein delivers a suite of technology and service solutions aimed at streamlining workflows and enhancing clinical outcomes.